LEADER 02752nam  2200577Ia 450 
001 9910458867403321
005 20200520144314.0
010   $a1-282-76098-X
010   $a9786612760983
010   $a92-9021-682-4
035   $a(CKB)2670000000033937
035   $a(EBL)538062
035   $a(OCoLC)781625393
035   $a(SSID)ssj0000422896
035   $a(PQKBManifestationID)11271158
035   $a(PQKBTitleCode)TC0000422896
035   $a(PQKBWorkID)10432667
035   $a(PQKB)10905482
035   $a(MiAaPQ)EBC538062
035   $a(Au-PeEL)EBL538062
035   $a(CaPaEBR)ebr10392231
035   $a(CaONFJC)MIL276098
035   $a(EXLCZ)992670000000033937
100   $a20090311d2009      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aMeasuring transparency to improve good governance in the public pharmaceutical sector$iJordan$b[electronic resource]
210   $aCairo, Egypt $cWorld Health Organization, Regional Office for the Eastern Mediterranean$dc2009
215   $a1 online resource (70 p.)
300   $aDescription based upon print version of record.
311   $a92-9021-649-2 
320   $aIncludes bibliographical references.
327   $aCOVER; TITLE; COPYRIGHT; Contents; Foreword; 7 Preface; Acknowledgements; Executive summary; 1. Introduction; 2. Overview of the public pharmaceutical sector in Jordan; 3. Methodology; 4. Results; 5. Data analysis and interpretation; 6. Recommendations; 7. Conclusions; Annexes
330   $aIn recent years, countries of the WHO Eastern Mediterranean Region have made significant achievements in the provision of health services. In the pharmaceutical field, countries have been striving to improve the structures and regulations pertaining to medicines and have progressed in many ways. However, there are still important challenges. The goal of the WHO Good Governance for Medicines programme is to improve the situation of medicines regulation and supply. National transparency assessment is the beginning of a process aimed at bringing about desirable and sustainable changes in the gove
606   $aPharmaceutical industry$xStandards$zJordan
606   $aPharmaceutical policy$zJordan
608   $aElectronic books.
615  0$aPharmaceutical industry$xStandards
615  0$aPharmaceutical policy
676   $a615.19
712 02$aWorld Health Organization.$bRegional Office for the Eastern Mediterranean.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910458867403321
996   $aMeasuring transparency to improve good governance in the public pharmaceutical sector$92069259
997   $aUNINA